KONINKLIJKE PHILIPS NV (PHIA.AS) Stock Fundamental Analysis

AMS:PHIA • NL0000009538

27.08 EUR
+0.09 (+0.33%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

PHIA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 63 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of PHIA have multiple concerns. PHIA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year PHIA was profitable.
  • PHIA had a positive operating cash flow in the past year.
  • In multiple years PHIA reported negative net income over the last 5 years.
  • Of the past 5 years PHIA 4 years had a positive operating cash flow.
PHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFPHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

1.2 Ratios

  • PHIA has a Return On Assets of 3.32%. This is comparable to the rest of the industry: PHIA outperforms 44.62% of its industry peers.
  • PHIA has a Return On Equity of 8.17%. This is comparable to the rest of the industry: PHIA outperforms 55.38% of its industry peers.
  • With a Return On Invested Capital value of 5.50%, PHIA perfoms like the industry average, outperforming 47.69% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for PHIA is significantly below the industry average of 9.88%.
  • The 3 year average ROIC (3.48%) for PHIA is below the current ROIC(5.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROIC 5.5%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.48%
ROIC(5y)N/A
PHIA.AS Yearly ROA, ROE, ROICPHIA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • The Profit Margin of PHIA (5.02%) is comparable to the rest of the industry.
  • PHIA's Profit Margin has declined in the last couple of years.
  • PHIA has a Operating Margin (7.98%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of PHIA has declined.
  • PHIA's Gross Margin of 45.18% is on the low side compared to the rest of the industry. PHIA is outperformed by 75.38% of its industry peers.
  • In the last couple of years the Gross Margin of PHIA has remained more or less at the same level.
Industry RankSector Rank
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
OM growth 3YN/A
OM growth 5Y-5.27%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
PHIA.AS Yearly Profit, Operating, Gross MarginsPHIA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PHIA is destroying value.
  • PHIA has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for PHIA has been increased compared to 5 years ago.
  • Compared to 1 year ago, PHIA has a worse debt to assets ratio.
PHIA.AS Yearly Shares OutstandingPHIA.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
PHIA.AS Yearly Total Debt VS Total AssetsPHIA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 2.11 indicates that PHIA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of PHIA (2.11) is worse than 60.00% of its industry peers.
  • The Debt to FCF ratio of PHIA is 16.37, which is on the high side as it means it would take PHIA, 16.37 years of fcf income to pay off all of its debts.
  • PHIA's Debt to FCF ratio of 16.37 is on the low side compared to the rest of the industry. PHIA is outperformed by 60.00% of its industry peers.
  • PHIA has a Debt/Equity ratio of 0.63. This is a neutral value indicating PHIA is somewhat dependend on debt financing.
  • The Debt to Equity ratio of PHIA (0.63) is worse than 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Altman-Z 2.11
ROIC/WACC0.84
WACC6.54%
PHIA.AS Yearly LT Debt VS Equity VS FCFPHIA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

  • PHIA has a Current Ratio of 1.32. This is a normal value and indicates that PHIA is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.32, PHIA is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.94 indicates that PHIA may have some problems paying its short term obligations.
  • PHIA has a Quick ratio of 0.94. This is in the lower half of the industry: PHIA underperforms 64.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.94
PHIA.AS Yearly Current Assets VS Current LiabilitesPHIA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.11% over the past year.
  • PHIA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.62% yearly.
  • The Revenue has decreased by -1.03% in the past year.
  • Measured over the past years, PHIA shows a small growth in Revenue. The Revenue has been growing by 0.59% on average per year.
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
Revenue 1Y (TTM)-1.03%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.42% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 3.77% on average over the next years.
EPS Next Y3.51%
EPS Next 2Y8.11%
EPS Next 3Y15.73%
EPS Next 5Y8.42%
Revenue Next Year1.71%
Revenue Next 2Y3.03%
Revenue Next 3Y3.53%
Revenue Next 5Y3.77%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PHIA.AS Yearly Revenue VS EstimatesPHIA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHIA.AS Yearly EPS VS EstimatesPHIA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • PHIA is valuated rather expensively with a Price/Earnings ratio of 18.42.
  • 80.00% of the companies in the same industry are more expensive than PHIA, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.07, PHIA is valued a bit cheaper.
  • With a Price/Forward Earnings ratio of 17.80, PHIA is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, PHIA is valued a bit cheaper than the industry average as 61.54% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of PHIA to the average of the S&P500 Index (28.05), we can say PHIA is valued slightly cheaper.
Industry RankSector Rank
PE 18.42
Fwd PE 17.8
PHIA.AS Price Earnings VS Forward Price EarningsPHIA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PHIA is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
  • PHIA's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 52.79
EV/EBITDA 12.31
PHIA.AS Per share dataPHIA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • PHIA's earnings are expected to grow with 15.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.24
PEG (5Y)N/A
EPS Next 2Y8.11%
EPS Next 3Y15.73%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • PHIA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

KONINKLIJKE PHILIPS NV

AMS:PHIA (2/27/2026, 7:00:00 PM)

27.08

+0.09 (+0.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)05-06
Inst Owners44.83%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap26.08B
Revenue(TTM)17.84B
Net Income(TTM)895.00M
Analysts73.33
Price Target29.32 (8.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.35
Dividend Growth(5Y)216.55%
DP36.65%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.02%
Min EPS beat(2)3.95%
Max EPS beat(2)14.1%
EPS beat(4)4
Avg EPS beat(4)17.83%
Min EPS beat(4)3.95%
Max EPS beat(4)31.04%
EPS beat(8)4
Avg EPS beat(8)2.84%
EPS beat(12)6
Avg EPS beat(12)6.47%
EPS beat(16)7
Avg EPS beat(16)6.93%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-0.86%
Revenue beat(4)0
Avg Revenue beat(4)-1.8%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)-0.86%
Revenue beat(8)0
Avg Revenue beat(8)-2.61%
Revenue beat(12)1
Avg Revenue beat(12)-2.36%
Revenue beat(16)2
Avg Revenue beat(16)-1.72%
PT rev (1m)7.88%
PT rev (3m)6.07%
EPS NQ rev (1m)-20.3%
EPS NQ rev (3m)-14.31%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.56%
Revenue NQ rev (1m)2.87%
Revenue NQ rev (3m)2.28%
Revenue NY rev (1m)-0.99%
Revenue NY rev (3m)-1.57%
Valuation
Industry RankSector Rank
PE 18.42
Fwd PE 17.8
P/S 1.46
P/FCF 52.79
P/OCF 22.44
P/B 2.38
P/tB N/A
EV/EBITDA 12.31
EPS(TTM)1.47
EY5.43%
EPS(NY)1.52
Fwd EY5.62%
FCF(TTM)0.51
FCFY1.89%
OCF(TTM)1.21
OCFY4.46%
SpS18.52
BVpS11.38
TBVpS-0.92
PEG (NY)5.24
PEG (5Y)N/A
Graham Number19.4
Profitability
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROCE 7.33%
ROIC 5.5%
ROICexc 6.42%
ROICexgc 22.25%
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
FCFM 2.77%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.48%
ROIC(5y)N/A
ROICexc(3y)3.99%
ROICexc(5y)N/A
ROICexgc(3y)13.73%
ROICexgc(5y)N/A
ROCE(3y)4.66%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1.19%
ROICexc growth 3YN/A
ROICexc growth 5Y-4.56%
OM growth 3YN/A
OM growth 5Y-5.27%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Debt/EBITDA 2.72
Cap/Depr 59.38%
Cap/Sales 3.75%
Interest Coverage 5.63
Cash Conversion 45.59%
Profit Quality 55.2%
Current Ratio 1.32
Quick Ratio 0.94
Altman-Z 2.11
F-Score7
WACC6.54%
ROIC/WACC0.84
Cap/Depr(3y)53.03%
Cap/Depr(5y)53.41%
Cap/Sales(3y)3.68%
Cap/Sales(5y)4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
EPS Next Y3.51%
EPS Next 2Y8.11%
EPS Next 3Y15.73%
EPS Next 5Y8.42%
Revenue 1Y (TTM)-1.03%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%
Revenue Next Year1.71%
Revenue Next 2Y3.03%
Revenue Next 3Y3.53%
Revenue Next 5Y3.77%
EBIT growth 1Y15922.2%
EBIT growth 3YN/A
EBIT growth 5Y-4.71%
EBIT Next Year68.56%
EBIT Next 3Y26.52%
EBIT Next 5Y17.27%
FCF growth 1Y-43.86%
FCF growth 3YN/A
FCF growth 5Y-22.31%
OCF growth 1Y-25.32%
OCF growth 3YN/A
OCF growth 5Y-15.14%

KONINKLIJKE PHILIPS NV / PHIA.AS FAQ

Can you provide the ChartMill fundamental rating for KONINKLIJKE PHILIPS NV?

ChartMill assigns a fundamental rating of 3 / 10 to PHIA.AS.


What is the valuation status of KONINKLIJKE PHILIPS NV (PHIA.AS) stock?

ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHIA.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for KONINKLIJKE PHILIPS NV?

KONINKLIJKE PHILIPS NV (PHIA.AS) has a profitability rating of 3 / 10.


How financially healthy is KONINKLIJKE PHILIPS NV?

The financial health rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 1 / 10.


Can you provide the dividend sustainability for PHIA stock?

The dividend rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 0 / 10 and the dividend payout ratio is 36.65%.